Approval · Notice of Compliance 4321 · 1996
CIPRO: Notice of Compliance 4321
Issued April 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4321
- Date
- April 19, 1996
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for an additional use: chronic bacterial prostatitis
- Therapeutic class
- Antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRO | Not yet assigned | — |
Medicinal ingredients
- CIPROFLOXACIN 500 MG per TAB